Low pulmonary vascular compliance predisposes post-Fontan patients to protein-losing enteropathy

Jeong Jin Yu1, Tae-Jin Yun, Sung-Cheol Yun

  • 1Division of Pediatric Cardiology, College of Medicine, University of Ulsan, Seoul, South Korea.

Insights

Protein-losing enteropathy (PLE) after Fontan surgery is a serious complication. Low pulmonary vascular compliance before surgery is a key risk factor for developing PLE after the extracardiac conduit Fontan operation.

Area of Science:

  • Cardiology
  • Pediatric Cardiology
  • Cardiovascular Surgery

Background:

  • Protein-losing enteropathy (PLE) is a severe complication following the Fontan operation.
  • The risk factors for developing PLE after the extracardiac conduit Fontan procedure remain poorly understood.
  • This study investigates pre-operative predictors of PLE in patients undergoing this specific surgical approach.

Purpose of the Study:

  • To identify pre-operative risk factors associated with protein-losing enteropathy (PLE).
  • To determine the relationship between pre-operative variables and the development of PLE post-extracardiac conduit Fontan operation.

Main Methods:

  • A cross-sectional retrospective study involving 235 patients who underwent an initial extracardiac conduit Fontan operation.
  • Pre-operative and peri-operative data were collected through medical record reviews.
  • Median age at operation was 3.5 years, with a median follow-up of 5 years.

Main Results:

  • 5.1% of patients (12/234) developed PLE at a median of 2.2 years post-operation.
  • Univariate analysis identified pulmonary vascular compliance (Cpv), central venous pressure, ICU stay, hospitalization duration, and chest tube indwelling as related factors.
  • Multivariate analysis confirmed that only low pulmonary vascular compliance (Cpv) remained a significant independent predictor of PLE (p=0.0367).

Conclusions:

  • Low pulmonary vascular compliance is significantly associated with the development of protein-losing enteropathy after the extracardiac conduit Fontan operation.
  • Identifying patients with low Cpv pre-operatively may aid in risk stratification and management strategies for preventing PLE.
Abstract

Related Concept Videos

Pulmonary Edema II: Pathophysiology01:18

Pulmonary Edema II: Pathophysiology

Pulmonary edema is the accumulation of fluid in the interstitial and alveolar spaces of the lungs, impairing gas exchange and oxygen delivery. It may be cardiogenic or noncardiogenic, but both reduce oxygenation and lung compliance.Cardiogenic Pulmonary EdemaCardiogenic edema results from increased hydrostatic pressure in pulmonary capillaries, usually due to left ventricular dysfunction from myocardial infarction, heart failure, or valvular disease. Ineffective cardiac pumping causes blood to...
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...